Craft

Skinvisible

Stock Price

$0.5

2024-10-29

Market Capitalization

$2.5 M

2024-10-29

Revenue

$20 K

FY, 2025

Skinvisible Summary

Company Summary

Overview
Skinvisible is an R&D pharmaceutical company that develops enhanced, patented dermatology and healthcare products to treat skin conditions from acne to warts, along with sunscreens, anti-aging products, hand sanitizing lotions, pre-surgical preparations, and medical treatments outside of dermatology using its patented technology Invisicare. Skinvisible's primary objective is to license these prescription and over-the-counter products into the global dermatology and medical markets.
Type
Public
Status
Active
Founded
1999
HQ
Las Vegas, NV, US | view all locations
Website
http://www.skinvisible.com/
Cybersecurity rating
Sectors

Key People

  • Terry Howlett

    Terry Howlett, President & Chief Executive Officer

    • Doreen McMorran

      Doreen McMorran, Vice President, Business Development

      • David st. James, Independent Director

        LocationsView all

        1 location detected

        • Las Vegas, NV HQ

          United States

          6320 S Sandhill Rd #10

        Skinvisible Financials

        Summary Financials

        Revenue (Q1, 2026)
        $5.0K
        Gross profit (Q1, 2026)
        $5.0K
        Net income (Q1, 2026)
        ($267.2K)
        Cash (Q1, 2026)
        $1.8K
        EBIT (Q1, 2026)
        ($125.9K)
        Enterprise value
        $11.7M

        Footer menu